MAP2K7 and melanoma: Immunotherapy and BRAF and MEK inhibitors have improved the survival rate of melanoma patients., However, a marginal number of patients have completely recovered but many patients have primary or acquired drug resistance.6 Chemotherapy is still an important treatment strategy for advanced melanoma patients who fail immunotherapy or targeted therapy.